Collaboration 4 Cure (C4C)
|
|
- Dorothy Harrell
- 6 years ago
- Views:
Transcription
1 Collaboration 4 Cure (C4C) 3 rd Call for Proposals from San Diego Alzheimer s Researchers: Alzheimer s San Diego, in partnership with the Salk Institute (Salk), Sanford Burnham Prebys Medical Discovery Institute (SBP), the Scripps Research Institute (Scripps), University of California, San Diego (UCSD), and the J. Craig Venter Institute (Venter), are seeking proposals for the locally funded and managed Collaboration 4 Cure (C4C), an innovative program to harvest the best research ideas and put them on a translational path towards effective therapies of Alzheimer s disease by partnering them with the existing local drug discovery infrastructure at SBP and Scripps. The C4C program will primarily award investigators the drug discovery capabilities and services of the Conrad Prebys Center for Chemical Genomics at SBP through contracts managed by Alzheimer s San Diego. Background: Collaboration 4 Cure is a ground-breaking initiative now in it s third year, led by Alzheimer s San Diego, the City and County of San Diego, and San Diego s premier research institutes to come together and combine resources to accelerate research drug discovery projects to find a cure for Alzheimer s disease right here in San Diego. The funding goal for the C4C is $7 million over the next five years. San Diego has a uniquely dynamic, entrepreneurial and creative science and technology heritage, with a track record of achievement in the creation, commercialization and sustainment of disruptive technologies emanating from its medical science-based companies and leading research institutes and universities. C4C is an innovative collaborative partnership amongst Alzheimer s San Diego and five institutions, the Salk, SBP Discovery, Scripps, UCSD, and the Venter, to provide access to world-class translational drug discovery infrastructure and expertise for collaborative, open-source, pre-competitive, early-stage research towards identifying and validating starting points for the development of new therapeutic small molecule agents that can progress to the clinical treatment for Alzheimer s disease and related dementias. Disclaimer: In late 2015, the Board of the San Diego/Imperial Chapter of the Alzheimer s Association decided to separate from the National Alzheimer s Association and Alzheimer s San Diego, an independent local organization was formed in order to best serve those affected by Alzheimer s and dementia in San Diego by ensuring a local governing board with local decision-making and that funds raised in San Diego remain in San Diego. Therefore, Alzheimer s San Diego is NOT affiliated with the Alzheimer s Association, the Alzheimer s Association San Diego/Imperial Chapter, the Alzheimer s Drug Discovery Foundation, the Alzheimer s Foundation of America (AFA) or the Bright Focus Foundation. General Considerations: Projects of interest will be those that benefit from the development and optimization of high-throughput screening (HTS) assay(s), assay automation, and synthetic chemistry capabilities. Successful awardees will be provided access to the assay development & HTS teams at SBP or Scripps technology cores to enable the development of screens through access to their drug discovery infrastructure. These efforts will culminate in a preliminary HTS data package, to include a pilot screen that demonstrates robustness and operating characteristics of the developed assay, and articulation of a cascade of follow-up assays needed to identify a valid hit compound. Projects that successfully achieve a robust preliminary HTS data package may be considered in subsequent years of this program for advancement through hit confirmation and validation to the screening of large chemical libraries of compounds. In parallel, it is anticipated that successful projects with robust HTS data packages may be used for joint applications to additional/alternate sources of funding, (e.g. for HTS screening of large chemical collections or the 370,000 NIH Molecular Libraries Small Molecules Repository (MLSMR) compounds through the NIH PAR RFA or additional grants from other agencies and foundations). Page 1 of 5
2 Important Deadlines: Letters of Intent (LOI) must be received by 5:00 PM Pacific Time on October LOIs will not be accepted after this date. No exceptions will be made. Letters of intent (LOI) are submitted directly to with the subject line C4C LOI submission. For those invited from their LOIs to submit a full proposal, these applications must be received by 5:00 PM Pacific Time on December 22, Scientific and technical review will be conducted between December 22, 2017 January 19, The C4C program will make final announcements of selected recipients no later than January 22, Important Deadlines Summary for this program are: August 18, 2017 Letter of Intent (LOI) Opens Monday, October 16, 2017 LOI deadline Monday, November 6, 2017 Full applications invited Friday, December 22, 2017 Full applications due Dec 22, 2017 Jan 19,2018 Review Period for full applications January 22, 2018 Anticipated award notifications Eligibility: Both academic, non-profit and small businesses with primary operations in San Diego are eligible. The C4C program is open to any principal investigator holding a faculty appointment at any accredited, greater San Diego area-based University, academic institution, hospital, medical practice or not-for-profit medical or life sciences research institution, inclusive of stakeholder institutes: Salk, SBP, Scripps, UCSD, and the Venter. All applicants will be required to obtain institutional endorsement of their research application from their respective home institutions. In addition, small business enterprise organizations (as defined by the Small Business Administration (SBA) Table of Small Business Size Standards under NAICS Codes , and and also meet NIH SBIR/STTR Eligibility Criteria) are eligible to apply. Small businesses must submit documentation of net assets and annual earnings for consideration during the letter of intent process. IMPORTANT: Consultation with either the SBP or Scripps Drug Discovery centers is encouraged in developing the LOI. Application Procedures: Both letters of intent (LOI) and invited applications are submitted directly to the Alzheimer s San Diego contact for this program: C4C@Alzsd.org with the subject line C4C LOI submission or C4C Invited Application submission. The LOI will consist of a two (2) page (8.5 x 11, 0.5 margins all around, 11-pt ARIAL font) that should ideally address the following: Background/Rationale why the target important, indication, genetics, proof of concept and citations Preliminary Data that verify (1) target modulation yields the desired phenotype and (2) technical feasibility of assays (robust, reproducible & scalable). Provide primary lab generated data and/or use/cite figures from key publication(s); embedded figures should be legible with legends in 8-pt ARIAL font) Experimental plans (approach, assay concept, format and cascade of hit progression assays) Readiness of homegrown reagents for the assay & follow-up cascade (necessary reagents created and qualified for stability, storage, freeze-thaw, performance, availability and scalable process for production. In addition, the applicant may include up to two (2) reference documents (in PDF format) to support their LOI. Each reference document may only include one paper, abstract or other documentation. Multiple references combined into one (1) PDF will not be accepted. LOIs will be evaluated and select investigators will be invited Page 2 of 5
3 to submit full applications. Additional information regarding review evaluation for LOIs and applications is included in Review Process section below. LOI Review Process: Letters of Intent (LOI) will be reviewed by a Joint Review & Operations Committee (JROC) comprising representatives from the Alzheimer s San Diego, representatives of San Diego Drug Discovery Consortium stakeholder institution, The criteria on which projects will evaluated are listed below with an emphasis on collaborative, translational research: Plausibility of the project based on known biology of proposed target and therapeutic agent for Alzheimer s disease or related dementias. Status of intellectual property, competition, freedom-to-operate or prior art of a process or reagent. Appropriateness of target for chemical modulation ( druggability ) and pre- or clinical proof-ofconcept (POC) studies. Technical feasibility of the project proposed, including the readiness of investigator-created reagents and current benchtop assays for screening. Outcomes of LOI review: After review, of the LOIs, applicants will receive 1 of 3 notification letters: 1) Non-responsiveness with some feedback of deficits from 2) Invitation to submit a full proposal these should be a 5-pages and include elements of the LOI with more specific details about: Research plan with clear and explicit definition of the hit progression cascade (including a flow chart of assays, go/no-go criteria, expected number of compounds, and clear definition of responsible party for each assay) Rationale and purpose for each secondary and tertiary assay on compounds that advance to that stage Availability of purchase, or path to scale up & produce key reagent(s) for the project (engineered or base cell lines, purified proteins, enzymes, antibodies) and estimates of their costs and time to delivery In cases where the applicant s lab is the only available source of key reagent(s) and/or key secondary (2 ) and tertiary (3 ) assay, a brief budget (total funds) and budget justification (table), with timelines for deliverables (see Available Funding below) Applicants are expected to develop the research plan in consultation with either SBP or Scripps with input in feasibility. They will develop a 1-page quotation for services and cost of materials, and time to achieve each milestone: (1) reagent transfer and scale up, (2) 1 and 2 assay developed and validated w/ pilot HTS (5K), (3) hit confirmation & validation from initial pilot hits through 1 and 2 by (SBP or Scripps) which will be part of the application. These full applications will be reviewed by the JROC supplemented with 2-3 external reviewers from local biotech or pharmaceutical companies. 3) Seed Supplementation towards assay feasibility LOI with robust meritorious target validation and rationale data/citations but lack robust technical assay feasibility may be invited for discussion to define a path to purchase or develop key qualified assay reagent(s) that would allow the first demonstration of the intended 1 st primary and secondary assay(s) that could be miniaturized and scaled for HTS. These could be for example engineered or base cell lines, purified proteins, enzymes, antibodies, custom signal generation & detection reagents. This supplementation could take the form of (1) direct purchase commercial of reagents or services by C4C agents on behalf and delivery to investigators, (2) access to SBP or Scripps Drug Discovery centers infrastructure and expertise to perform key reagent generation or assay development activities, or (3) if reagents are unique to the investigator, with approval investigator s mentor and investigator s institutional policies total funds of up to $15,000 in the form of a contract to the investigators (not a research grant) for time/milestone Page 3 of 5
4 driven delivery the final product and use in assay development. Awardees who successfully develop robust feasibility data as judged by a JROC review will be subsequently invited to submit a full proposal for award without re-submission of an LOI off cycle of the LOI deadline. Available Funding: The primary purpose of the C4C program is to provide access to early drug discovery capabilities rather than direct transfer of funds to individual investigator laboratories. Award will provide services to investigators in the form of early drug discovery capabilities and is not a direct funding mechanism for individual investigator laboratories. Successful applicants will partner with, and obtain access to resources and services of the Sanford Burnham or Scripps drug discovery centers including assay automation, HTS, and synthetic chemistry capabilities, which can be applied to the discovery and development of innovative first-inclass compounds that have the potential to be developed into therapeutics. The funds will be administered by the Alzheimer s San Diego and use to remit against approved quotes for services to these partnered centers. In very specialized cases, with approval of the Joint Steering Committee limited funds may be made available to a PI s laboratory to enable, for example, production of unique critical reagents or key assays or services that only the PI s laboratory can perform. Investigator will submit invoices against pre-appoved service quotes. Please note that the C4C program is a unique funding opportunity that provides access to resources or specific supplemental funding to achieve drug discovery and translational critical path items and is NOT meant to replace or augment existing research grants directed towards basic research or to recruit new research personnel, launch major new research directions, fund general operating support for the lab or to purchase equipment. Mechanism of award, reporting requirements and allowable costs: The mechanism of the award is to provide access to early drug discovery capabilities rather than direct transfer of funds to individual investigator laboratories. It is expected that successful applicants will confer bi-monthly or as needed with the project team and JROC to reach milestones submitted in final project plans. Continuation of the funding during the project s duration is contingent upon review of the scientific progress towards milestones and spending during JROC meetings. In such cases, where project have reached a scientific or technical impasse, the unspent, noninvoiced funds may be redeployed to other projects in the overall C4C portfolio upon recommendation by the JROC and approval by the JSC. PI of such defunded or terminated projects may wish to reapply if they are able to demonstrate the prior impasse has been overcome (technically or new research) and that novelty and relevance are still maintained. Budget and Duration: For this first year, the C4C program anticipates funding multiple awards with service quotations of $35,000 - $65,000 for each project, depending on assay complexity. Duration of awards is one (1) year and contingent upon attainment of specific milestones. In future years, it is envisioned that projects that successfully achieve a robust preliminary HTS data package may be advanced for funding of larger scale HTS, (10,000-75,000 compounds), followed by hit confirmation, validation and expansion in the subsequent year (year 2), through an expedited, competitive review. It is expected that the robust and complete data obtained by this additional funding will serve as a preliminary data packet to support submission of an NIH R01 HTS grant or become drug discovery HTS aim of a larger program grant. The relevant portions of the Research Plan of a submitted R01 will suffice as the final scientific report of the project to the JROC and JSC. Confidentiality: Consistent with the Alzheimer s San Diego policies, members of all committees will not share the information provided by applicants through the registration and application process except with directors, officers and/or representatives of stakeholder institutions, as deemed necessary. Nonetheless, applicants should not provide confidential information, such as chemical structures, at the LOI stage. Materials and Data Sharing: Awarded applicants will be required to provide necessary, unique reagents that Page 4 of 5
5 are not commercially available and necessary for their proposal, such as cells expressing recombinant enzymes/proteins, primary and secondary antibodies, tagged peptide substrates, and available positive controls (e.g., a known inhibitor of the target) to the partnered translational partners (SBP or Scripps) under an MTA for the purposes of this C4C pre-competitive program. Intellectual Property: All pre-existing intellectual property will remain the exclusive property of the party that created it prior to or independent of the funded research. During the term of the funding period, new inventions will be subject to Alzheimer s San Diego s Patent Policy existing with or to be signed with the grantee institutions at time of award. For more information about any of the grant schemes or the application process, please contact the Alzheimer s San Diego at C4C@alz.org and your will be directed to the scientific and program staff, who will respond by or phone within 2-3 days. Page 5 of 5
Crohn s & Colitis Foundation Entrepreneurial Investing Award
Crohn s & Colitis Foundation Entrepreneurial Investing Award Program Guidelines Effective December 4, 2017 Crohn s & Colitis Foundation National Office Research & Scientific Programs Department 733 Third
More informationTHE MARILYN HILTON AWARD FOR INNOVATION IN MS RESEARCH BRIDGING AWARD FOR PHYSICIAN SCIENTISTS Request for Proposals
THE MARILYN HILTON AWARD FOR INNOVATION IN MS RESEARCH BRIDGING AWARD FOR PHYSICIAN SCIENTISTS Request for Proposals Conrad N. Hilton Foundation Established in 1944 by the founder of Hilton Hotels, the
More informationREQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER
REQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER APPLICATION DEADLINE: 5 pm, Monday, January 22, 2018 PURPOSE The Ming Hsieh Institute aims to make USC an international
More information2018 Request for Applications for the following two grant mechanisms Target Identification in Lupus Program & Novel Research Grant Program
2018 Request for Applications for the following two grant mechanisms Target Identification in Lupus Program & Novel Research Grant Program Release Date: November 3, 2017 Application Due Date: February
More informationTECHNOLOGY DEVELOPMENT PROGRAM
TECHNOLOGY DEVELOPMENT PROGRAM REQUEST FOR APPLICATIONS JANUARY 2018 (ROUND 10) KEY DATES RFA released January 10, 2018. Letters of Intent due February 16, 2018. Selected LOI submissions invited to submit
More informationScreen to Lead Program (SLP)
Screen to Lead Program (SLP) INTRODUCTION The Leukemia & Lymphoma Society (LLS) is sponsoring and issuing this Request for Applications (RFA) from qualified academic laboratories for drug discovery support
More informationCureSearch Young Investigator Awards in Pediatric Oncology Drug Development Request for Applications and Guidelines
CureSearch Young Investigator Awards in Pediatric Oncology Drug Development 2017 Request for Applications and Guidelines Accelerate the Search: Find the Cure Driving research to improve the odds for those
More information***** PROTEOMICS SEED GRANT RFP (BMGC 2005) *****
***** PROTEOMICS SEED GRANT RFP (BMGC 2005) ***** PURPOSE The University of Minnesota s BioMedical Genomics Center (BMGC) announces the availability of seed funds to assist investigators interested in
More informationREQUEST FOR PROPOSALS August 1, 2016
2016-2017 REQUEST FOR PROPOSALS August 1, 2016 The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for highimpact translational research that has the potential to
More informationUNC Lineberger Developmental Funding Program. Proposal Due Dates: 5:00pm March 15 and September 15
Proposal Due Dates: 5:00pm March 15 and September 15 Letter of Intent for Tier 3: Multi-Project Awards due three weeks before due date The UNC Lineberger Developmental Funding Program is intended to support
More informationMSCRF Discovery Program
www.mscrf.org REQUEST FOR APPLICATIONS (RFA) MSCRF Discovery Program INTRODUCTION: Stem cell research offers extraordinary promise for new medical therapies and a better understanding of debilitating human
More informationWest Virginia Clinical and Translational Science Institute Open Competition RFA
West Virginia Clinical and Translational Science Institute Open Competition RFA Part 1. Overview Information The goal of this Request for Applications (RFA) is to support clinical and translational pilot
More informationParker Institute for Cancer Immunotherapy Stanford Medicine Stanford Medicine Bedside to Bench Grant Program Call for Proposals
Parker Institute for Cancer Immunotherapy (PICI) @ Stanford Medicine PICI @ Stanford Medicine Bedside to Bench Grant Program Call for Proposals Letter of intent deadline: Monday, Dec. 12, 2016 The Parker
More informationCURE INNOVATOR AWARD Promoting Innovation
CURE INNOVATOR AWARD Promoting Innovation The CURE Innovator Award supports the exploration of a highly innovative, often risky new concept or untested theory that addresses an important problem relevant
More informationCureSearch Acceleration Initiative 2 (AI-2) International Grand Challenge Awards in Pediatric Cancer
CureSearch Acceleration Initiative 2 (AI-2) International Grand Challenge Awards in Pediatric Cancer 2015 Request for Applications (RFA) Funded in partnership with the Rising Tide Foundation for Clinical
More informationMRC Funding and Translational Research. Dr Catriona Crombie
MRC Funding and Translational Research Dr Catriona Crombie Medical Research Council The Medical Research Council is dedicated to improving human health through the best scientific research. Its work, on
More informationCatalyst Fund Intermediate Awards Program
Catalyst Fund Intermediate Awards Program Application deadline, November 9 th 2018 The project start date for awardees is no earlier than January 15 th, 2019 Interested applicants are welcome to seek pre-submission
More informationSouthern California NIOSH Education and Research Center (SCERC): Guidelines for Pilot Project Research Training Program Grant Applicants (FY 2017/18)
Southern California NIOSH Education and Research Center (SCERC): Guidelines for Pilot Project Research Training Program Grant Applicants (FY 2017/18) A. Purpose The main objectives of this program are
More informationFull application deadline Noon on April 4, Presentations to Scientific Review Committee (if invited) May 11, 2016
Request for Applications: Pilot Project Funding for Catalyzing Translational Research Opportunities KEY DATES Full application deadline Noon on April 4, 2016 Presentations to Scientific Review Committee
More informationMelanoma Research Alliance REQUEST FOR PROPOSALS
Melanoma Research Alliance 2013-2014 REQUEST FOR PROPOSALS Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and
More informationProposal Submission Instructions. Proposal Formatting Instructions. Required Proposal Components. Research Proposal, Fiscal Year 2014
Proposal Submission Instructions The complete proposal must be received by close of business (5 PM PST) August 30, 2013. Proposals submitted after this date will not be reviewed. Prior submission and approval
More informationThe Marilyn Hilton Award for Innovation in MS Research PILOT INNOVATOR GRANTS Request for Proposals
The Marilyn Hilton Award for Innovation in MS Research PILOT INNOVATOR GRANTS Request for Proposals Conrad N. Hilton Foundation Established in 1944 by the founder of Hilton Hotels, the Conrad N. Hilton
More informationWest Virginia Clinical and Translational Science Institute Small Grants RFA
West Virginia Clinical and Translational Science Institute Small Grants RFA Part 1. Overview Information Limited funds are available for the WVCTSI Small Grants Program to support small, welldefined projects
More informationPilot & Collaborative Studies (PCS) Funding Program FAQs
Pilot & Collaborative Studies (PCS) Funding Program FAQs What is PCS? The Center for Clinical and Translational Science and Training (CCTST) is supported by a NIH Clinical and Translational Sciences Award
More informationUNIVERSITY TECHNOLOGY ACCELERATION GRANT (UTAG) FY18 FALL PROGRAM ANNOUNCEMENT
UNIVERSITY TECHNOLOGY ACCELERATION GRANT (UTAG) FY18 FALL PROGRAM ANNOUNCEMENT Note to prospective applicants: Please read this announcement carefully and thoroughly. Aspects of eligibility, targeted technology
More informationThe Hope Foundation SEED Fund for SWOG Early Exploration and Development 2016 Announcement
The Hope Foundation SEED Fund for SWOG Early Exploration and Development 2016 Announcement OVERVIEW SWOG s mission is to improve the practice of cancer medicine in preventing, detecting, and treating cancer,
More informationREQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER 2015 RESEARCH AWARD
REQUEST FOR PROPOSALS MING HSIEH INSTITUTE FOR RESEARCH ON ENGINEERING-MEDICINE FOR CANCER 2015 RESEARCH AWARD APPLICATION DEADLINE: 5:00 pm, Friday, January 23, 2015 NEW DEADLINE PURPOSE The Ming Hsieh
More informationREQUEST FOR PROPOSALS THE ROSE HILLS FOUNDATION INNOVATOR GRANT PROGRAM RESEARCH FELLOWSHIP APPLICATION
REQUEST FOR PROPOSALS THE ROSE HILLS FOUNDATION INNOVATOR GRANT PROGRAM RESEARCH FELLOWSHIP APPLICATION APPLICATION DEADLINE: 12:00 pm., Monday, January 9, 2017 PURPOSE The Rose Hills Foundation is a legacy
More informationDuke/UNC Chapel Hill CTSA Consortium Collaborative Translational Research Pilot Grants Request for Applications
Duke/UNC Chapel Hill CTSA Consortium Collaborative Translational Research Pilot Grants Request for Applications The Duke Translational Research Institute (DTRI) and North Carolina Translational and Clinical
More informationENGineering for Innovation & ENtrepreneurship (ENGINE) Grants
ENGineering for Innovation & ENtrepreneurship (ENGINE) Grants The Penn State Fund for Innovation is committed to fostering the translation of basic research into technologies that show immediate potential
More informationPfizer-NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy Application Guidelines & Instructions
Pfizer-NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy Application Guidelines & Instructions Application Essentials The deadline to submit applications to the Pfizer- NCBiotech Distinguished
More informationELI LILLY-STARK NEUROSCIENCES POST-DOCTORAL RESEARCH FELLOWSHIP IN NEURODEGENERATION
Request for Applications ELI LILLY-STARK NEUROSCIENCES POST-DOCTORAL RESEARCH FELLOWSHIP IN NEURODEGENERATION a joint initiative between ELI LILLY AND COMPANY & STARK NEUROSCIENCES RESEARCH INSTITUTE INDIANA
More informationMilestones. RFAs announced November 29, Letter of intent due January 31, Application due March 30, Award announcement June 1, 2018
Milestones RFAs announced November 29, 2017 Letter of intent due January 31, 2018 Application due March 30, 2018 Award announcement June 1, 2018 Funds made available (pending IRB approval) July 2, 2018
More informationINVESTIGATORS IN THE PATHOGENESIS OF INFECTIOUS DISEASE (PATH) Invited full proposal deadline: November 15, 2017
INVESTIGATORS IN THE PATHOGENESIS OF INFECTIOUS DISEASE (PATH) Invited full proposal deadline: November 15, 2017 TABLE OF CONTENTS Key Dates and Program Background 3 Eligibility Requirements 3 Selection
More informationCYSTIC FIBROSIS FOUNDATION
CYSTIC FIBROSIS FOUNDATION Second Year Clinical Fellowship Application POLICIES AND GUIDELINES December 7, 2016 Cystic Fibrosis Foundation 6931 Arlington Road, Suite 200 Bethesda, MD 20814 Grants and Contracts
More information2017 State of Connecticut Regenerative Medicine Research Fund (RMRF) General RFP
2017 State of Connecticut Regenerative Medicine Research Fund (RMRF) General RFP (Seed, Established Investigator, Group) Full RFP, Forms and additional FAQs: http://ctinnovations.com/rmrf Deadline Friday,
More informationDESIGN AND BIOSTATISTICS PROGRAM (DBP) PILOT GRANT
Request for Applications DESIGN AND BIOSTATISTICS PROGRAM (DBP) PILOT GRANT INDIANA CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE LETTER OF INTENT DUE: December 18, 2017 FULL APPLICATION ELECTRONIC RECEIPT
More informationREQUEST FOR APPLICATIONS Post-Traumatic Epilepsy
REQUEST FOR APPLICATIONS Post-Traumatic Epilepsy Program Goal: To support collaborative, milestone-driven efforts that advance the understanding of epilepsy as a result of traumatic brain injury. CURE
More informationKidney Cancer Association P.O. Box #38269 Chicago, IL Tel
Kidney Cancer Association Young Investigator Award Request for Proposals (RFP) Entire application process is to be completed only by email Important Dates Grant cycle begins: October 30 Abstract deadline:
More informationPfizer-NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy Application Guidelines & Instructions (UPDATED )
Pfizer-NCBiotech Distinguished Postdoctoral Fellowship in Gene Therapy Application Guidelines & Instructions (UPDATED 6-7-18) REVISIONS: 1) New deadline for submission of application (page 1). 2) The restriction
More informationMSM Research Grant Program 2018 Competition Guidelines
MSM Research Grant Program 2018 Competition Guidelines These Guidelines describe the requirements for the Canadian Blood Services MSM Research Grant program. The MSM Research Grant program terms and conditions
More information2018 Innovation to Commercialization (I2C) Kate Wilczak Coordinator, Research Competitions
2018 Innovation to Commercialization (I2C) Kate Wilczak Coordinator, Research Competitions Presentation Agenda Insights from a past I2C Award recipient Program Objectives Award Amount and Duration Eligibility
More informationTARGETED RFA IN PROSTATE CANCER RESEARCH Predictive Markers
TARGETED RFA IN PROSTATE CANCER RESEARCH Predictive Markers Revised 20180504 *see p. 3 sentence revised Part 1: Overview Information Participating Organization(s) Funding Opportunity Title Description
More informationWallace H. Coulter Center for Translational Research 2016 Commercialization Grant
Wallace H. Coulter Center for Translational Research 2016 Commercialization Grant RFP Issued: Nov 17, 2014 Due Date: 8:00 a.m. Tuesday Jan 6, 2015 Oral presentations: March, 2015 Award Notification: April,
More informationREQUEST FOR PROPOSALS JAMES H. ZUMBERGE FACULTY RESEARCH & INNOVATION FUND ZUMBERGE INDIVIDUAL RESEARCH AWARD
REQUEST FOR PROPOSALS JAMES H. ZUMBERGE FACULTY RESEARCH & INNOVATION FUND ZUMBERGE INDIVIDUAL RESEARCH AWARD APPLICATION DEADLINE: 5 pm, Monday, January 8, 2018 PURPOSE The primary purpose of the Zumberge
More informationMovember Clinician Scientist Award (CSA)
Movember Clinician Scientist Award (CSA) Part 1: Overview Information Participating Organisation(s) Funding Category Description The Movember Foundation and Prostate Cancer Foundation of Australia Movember
More information$75,000 Total ($37,500 per year) 24 months
Arkansas Children s Research Institute Funding Opportunity: ABI Discovery Acceleration Initiative in Pediatric Medicine Investigator Initiated Research Awards Program Overview Program Purpose Eligibility
More informationALK Positive/LUNGevity Foundation 2018 Request for Application
ALK-Positive Lung Cancer Transformational Research Program IMPORTANT NOTES TO READ BEFORE PROCEEDING: ALK Positive is partnering with LUNGevity Foundation ( LUNGevity ) to fund research into ALK-positive
More informationLife Sciences Simons Collaboration on the Origins of Life Fellowship Policies and Procedures
Life Sciences Simons Collaboration on the Origins of Life Fellowship Policies and Procedures Table of Contents 1. Our mission Page 2 2. Online fellowship management Page 2 3. Fellowship activation Page
More informationAlpha-1 Foundation Letter of Intent and Full Application Instructions
Alpha-1 Foundation Letter of Intent and Full Application Instructions 2017-2018 In-Cycle Grants VERSION 2 July 17, 2017 Alpha-1 Foundation 3300 Ponce de Leon Blvd. Coral Gables, FL 33134 TABLE OF CONTENTS
More informationSTANFORD CANCER INSTITUTE 2019 CANCER INNOVATION AWARDS Full Proposal Submission Guidelines
STANFORD CANCER INSTITUTE 2019 CANCER INNOVATION AWARDS Full Proposal Submission Guidelines Deadline for Full Proposal: Friday, November 9, 2018 Stanford Cancer Institute s (SCI) mission is to translate
More informationFunding Opportunity Public Health Collaboratory Award Letter of Intent Deadline: January 19, 2017 Full Proposal Deadline: Feb 24, 2017
Funding Opportunity Public Health Collaboratory Award Letter of Intent Deadline: January 19, 2017 Full Proposal Deadline: Feb 24, 2017 Introduction and Background The Iowa Institute of Public Health Research
More informationThe application must include the following items:
THE VASCULAR MEDICINE INSTITUTE (VMI) AND THE CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE (CTSI) ANNOUNCE THE PILOT PROJECT PROGRAM IN HEMOSTASIS AND VASCULAR BIOLOGY (Revised, January 2015) The VMI was
More informationApart from PIs and RSEs, other applicants under the Startup SG Tech must meet the following eligibility criteria:
Startup SG Tech FAQ A. Eligibility 1. What are the eligibility criteria under Startup SG Tech? The Startup SG Tech is primarily aimed at startups that are registered or incorporated in Singapore and physically
More informationIndiana University Health Values Fund Grant Pilot & Feasibility Program - Research
Request for Applications Indiana University Health Values Fund Grant Pilot & Feasibility Program - Research a joint initiative between INDIANA UNIVERSITY HEALTH & INDIANA CLINICAL AND TRANSLATIONAL SCIENCES
More informationRe-issued RFA: 20 September 2016
Arkansas Children s Research Institute Funding Opportunity: ABI Discovery Acceleration Initiative in Pediatric Medicine Program Project Planning Grants Re-issued RFA: 20 September 2016 Program Overview
More informationLEWIS FOUNDATION GRANT PROGRAM Lewis College of Nursing & Health Professions Application Deadline: March 1, 2018
LEWIS FOUNDATION GRANT PROGRAM Lewis College of Nursing & Health Professions Application Deadline: March 1, 2018 PURPOSE & GENERAL INFORMATION ABOUT AWARD The purpose of the Lewis Foundation Grant is to
More informationOregon Clinical and Translational Research KL2 Program
Request for Applications www.octri.org/octrikl2 2014 OCTRI KL2 RFA (updated 12/19/2013) Page 1 of 8 Oregon Clinical and Translational Research KL2 Program Letter of Intent deadline: January 13, 2014 Extended
More informationCYSTIC FIBROSIS FOUNDATION
CYSTIC FIBROSIS FOUNDATION Screening Improvement Program (SIP) for Optimizing the Diagnosis of Infants Award POLICIES AND GUIDELINES Published: January 17, 2018 Application Deadline: April 2, 2018 Cystic
More informationSPH Seed Funding Program
SPH Seed Funding Program Academic Year 2017-18 JANUARY 2018 COMPETITION SPH Office of Research Services REVISED 11/16/2017 Table of Contents Overview Information... 2 Program Guidelines... 3 Program Description...
More informationOregon Clinical and Translational Research KL2 Program
Request for Applications www.octri.org/octrikl2 Oregon Clinical and Translational Research KL2 Program Letter of Intent deadline: April 3, 2017 The OCTRI Education Program is accepting letters of intent
More informationALS Canada-Brain Canada Discovery Grants
ALS Canada-Brain Canada Discovery Grants Terms of Reference I) OVERVIEW The Discovery Grants program has been established to encourage new basic research focused on identifying causes of, or treatments
More informationa. Community-placed/based research b. Sporadic or symbolic inclusion of communities c. A specific method or research design
University of Rochester Medical Center Clinical and Translational Science Institute (CTSI) Request for Applications Community-Based Participatory Research (CBPR) Pipeline-to-Pilot Awards For Projects Beginning
More informationREQUEST FOR APPLICATIONS RFA R-18.1-RFT
REQUEST FOR APPLICATIONS RFA R-18.1-RFT Recruitment of First-Time Tenure-Track Faculty Members Please also refer to the Instructions for Applicants document, which will be posted on June 21, 2017 Application
More informationVenture Development Fund Request for Proposals
Venture Development Fund Request for Proposals Summary The State of Oregon, through legislation encouraging philanthropic donations targeted to support the commercialization of research at Oregon s Universities,
More informationChildhood Cancer Research Seed Grants Full Proposal Application Guidelines
Childhood Cancer Research Seed Grants Full Proposal Application Guidelines Who We Are The Pablove Foundation invests in underfunded, cutting-edge pediatric cancer research, and improves the lives of children
More informationSupported by the SFI-HRB-Wellcome Trust Biomedical Research Partnership
WELLCOME TRUST Institutional Strategic Support Fund Supported by the SFI-HRB-Wellcome Trust Biomedical Research Partnership Medical Humanities and Social Sciences Collaborative Scheme Call Document INTRODUCTION...
More informationSCIENCE COMMITTEE PROGRAMME FOUNDATION AWARDS OUTLINE APPLICATION GUIDELINES
SCIENCE COMMITTEE PROGRAMME FOUNDATION AWARDS OUTLINE APPLICATION GUIDELINES CONTENTS i. CHECKLIST... 2 1. INTRODUCTION... 3 1.1. Purpose of the guidelines... 3 1.2. About CRUK... 3 1.3. About the award...
More informationTerms of Reference: ALS Canada Project Grant Program 2018
Terms of Reference: ALS Canada Project Grant Program 2018 Overview The 2018 Project Grant Program encompasses applications previously designated for Discovery, Bridge or Clinical Management Grant competitions.
More informationAzrieli Foundation - Brain Canada Early-Career Capacity Building Grants Request for Applications (RFA)
Azrieli Foundation - Brain Canada Early-Career Capacity Building Grants Request for Applications (RFA) About the Azrieli Foundation For almost 30 years, the Azrieli Foundation has funded institutions as
More informationNIDA-AACAP Resident Training Award Application
NIDA-AACAP Resident Training Award Application NIDA-AACAP Resident Training Award in Substance Use Disorder, supported by the National Institute on Drug Abuse (NIDA) from the National Institutes of Health
More informationTHE VASCULAR MEDICINE INSTITUTE (VMI) ANNOUNCES THE PILOT PROJECT PROGRAM IN HEMOSTASIS AND VASCULAR BIOLOGY (Revised, November 2017)
THE VASCULAR MEDICINE INSTITUTE (VMI) ANNOUNCES THE PILOT PROJECT PROGRAM IN HEMOSTASIS AND VASCULAR BIOLOGY (Revised, November 2017) The VMI was established at the University of Pittsburgh in 2008 as
More informationSEED FUNDING PROGRAM
SEED FUNDING PROGRAM About the Program The National Institutes of Health (NIH) awarded a U54 cooperative agreement to the University of Texas at El Paso to develop the BUILDing SCHOLARS Center (BUilding
More informationSCHOOL OF ENERGY RESOURCES Rare Earth Element Research
School of Energy Resources Energy Innovation Center Dept. 3012, 1000 E. University Ave., Laramie, WY 82071 (307) 766-6896 http://www.uwyo.edu/ser/ June 15, 2015 Request for Proposals SCHOOL OF ENERGY RESOURCES
More informationSBIR ADVANCE GRANT APPLICATION GUIDELINES Next Deadline: 4:00PM CDT November 24, 2014
SBIR ADVANCE GRANT APPLICATION GUIDELINES Next Deadline: 4:00PM CDT November 24, 2014 Items referred to in this document needed to complete your application: o Cover Page with signed SBIR Advance Agreement
More informationBARD Research Proposals Guidelines and Regulations for Applicants. (Updated: July 2014) Table of Contents
(Updated: July 2014) Table of Contents Mission... 2 Cooperative Research Typical Grant Feasibility Studies BARD Priorities Eligibility... 3 Investigators (PI, Co-PI, Collaborating, early career scientists)
More informationClinical Investigator Career Development Award ( )
Clinical Investigator Career Development Award (2018-2021) Guidelines and General Instructions for Application KEY DATES Application Release Date: May 24, 2017 Application Deadline: September 6, 2017 at
More informationWest Virginia Clinical and Translational Science Institute Request for Applications
West Virginia Clinical and Translational Science Institute Request for Applications Part 1. Overview Information Funding Opportunity Purpose The goal of this Request for Applications (RFA) is to support
More information2017 REQUEST FOR APPLICATION (RFA)
Lung Cancer Foundation of America-Bristol-Myers Squibb/ International Association for the Study of Lung Cancer Young Investigator Research Awards in Translational Immuno-oncology 2017 REQUEST FOR APPLICATION
More informationRequest for Proposals (RFP) Hemostasis and Thrombosis Research Society (HTRS)
Request for Proposals (RFP) Hemostasis and Thrombosis Research Society (HTRS) 2018 HTRS/Novo Nordisk Clinical Fellowship Awards in Hemophilia and Rare Bleeding Disorders Applications are due Monday, January
More informationPostdoctoral Fellowships ( )
Postdoctoral Fellowships (2018-2020) Guidelines and General Instructions for Application KEY DATES Application Release Date: May 24, 2017 Application Deadline: September 6, 2017 at 5:00 PM EST Peer Review
More informationThe AOFAS Research Grants Program Description, Policies, and Guidelines for Applicants and Institutional Representatives
The AOFAS Research Grants Program Description, Policies, and Guidelines for Applicants and Institutional Representatives Updated October 2016 for the 2017 Grants Cycle Table of Contents ABOUT THE AOFAS
More informationLETTER OF INTENT INSTRUCTIONS
LETTER OF INTENT INSTRUCTIONS The objective of the American Lung Association Lung Cancer Discovery Award is to support clinical, laboratory, epidemiological, or any other kind of research projects aimed
More informationDuke SCORES Department of Surgery Duke University Medical Center Box 2945 Durham, NC Ph:
Duke SCORES Scholars Program REQUEST FOR APPLICATIONS Application Deadline: August 7, 2017 Duke SCORES (Surgical Center for Outcomes Research) is a novel, transdisciplinary effort that promotes excellence
More informationInnovative Research Award
Innovative Research Award The mission of the Rheumatology Research Foundation is to advance research and training to improve the health of people with rheumatic disease. Purpose: The Innovative Research
More informationSpecialized Center of Research Program Guidelines & Instructions. Letter of Intent & Full Application
Specialized Center of Research Program Guidelines & Instructions Letter of Intent & Full Application Effective dates: May 1, 2018 April 30, 2019 Table of Contents 2018 Updates...2 About The Leukemia &
More informationARG/AR-WITAG ELIGIBILITY AND GUIDELINES
APPLIED RESEARCH GRANT PROGRAM (ARG) AND APPLIED RESEARCH-WiSys TECHNOLOGY ADVANCEMENT GRANT PROGRAM (AR-WiTAG) AND PROTOTYPE DEVELOPMENT FUND PROGRAM (PDF) REQUEST FOR PROPOSALS AND APPLICATION GUIDELINES
More informationASTRO 2015 Junior Faculty Career Research Training Award
ASTRO 2015 Junior Faculty Career Research Training Award I. Funding Opportunity AWARD REQUIREMENTS AND OBLIGATIONS A. Funding Opportunity The Junior Faculty Career Research Training Award aims to stimulate
More informationInstitute for Clinical and Translational Research The Johns Hopkins Clinical Research Network
Johns Hopkins Center for Women s Health, Sex, and Gender Research and The Foundation for Gender-Specific Medicine Request for Applications (RFA) for Seed Grants for Research on Sex/Gender Differences in
More informationSAMPLE Grant and Fellowship Program Frequently Asked Questions
SAMPLE Grant and Fellowship Program Frequently Asked Questions For more information, visit https://preventcancer.org/research/researcher-profiles/#awardees to view past award recipients, researcher profiles
More informationAUR Research and Education Foundation Strategic Alignment Grant
AUR Research and Education Foundation Strategic Alignment Grant Guidelines and Application Purpose To advance the long-range strategic organizational goals of the AUR by awarding one year length grant(s)
More informationBARD Research Proposals Guidelines and Regulations for Applicants
(Updated: July 2017) Table of Contents Mission... 2 Cooperative Research... 2 BARD Award... 2 Feasibility Studies... 2 BARD Priorities... 2 Eligibility... 3 BARD postdoctoral fellows... 3 Investigators...
More informationPromoting Health Equity by Including Underrepresented Participants in Research REQUEST FOR APPLICATIONS
Promoting Health Equity by Including Underrepresented Participants in Research REQUEST FOR APPLICATIONS PLEASE NOTE: Two required steps before applying in response to this RFA are to submit a 250-word
More informationAACAP Marilyn B. Benoit, MD, Child Maltreatment Mentorship Award Application
AACAP Marilyn B. Benoit, MD, Child Maltreatment Mentorship Award Application PURPOSE OF THE AWARD The purpose of this award is to provide either a child and adolescent psychiatry resident, child and adolescent
More informationGrant Application Form
Grant Application Form Date of Application: Legal Name of Organization: Executive Director: Contact Person/Title: Email: Organization Website: EIN: Address: City, State, Zip: Phone Number: Fax Number:
More informationThe LOI is only to allow organization of the review process, and all projects submitting an LOI will be permitted to submit a full application.
A Complete Grant Application will include the following: 1) LOI Form submitted by May 15, 2017 An electronic letter of intent (LOI) submission form is required 30 days before the deadline for full application
More informationPolicies and Procedures for Team Science Grants (TSG) Supported by Simmons Cancer Institute at SIU
Policies and Procedures for Team Science Grants (TSG) Supported by Simmons Cancer Institute at SIU TSG Award Goals and Scope The Simmons Cancer Institute at SIU (SCI) is seeking to fund proposals led by
More informationRequest for Proposals (RFP) Hemostasis and Thrombosis Research Society (HTRS) 2018 HTRS Mentored Research Award (MRA) Program
Request for Proposals (RFP) Hemostasis and Thrombosis Research Society (HTRS) 2018 HTRS Mentored Research Award (MRA) Program 2018 MRA Pre-proposals are due Friday, September 8, 2017 by 6:00 p.m. ET (deadline
More informationFONDATION VAINCRE ALZHEIMER 2018 GRANT APPLICATION GUIDELINES
FONDATION VAINCRE ALZHEIMER 2018 GRANT APPLICATION GUIDELINES Statement of Purpose Fondation Vaincre Alzheimer awards grants for basic, translational and clinical research into the underlying mechanisms
More informationAlpha-1 Foundation Letter of Intent Application Instructions
Alpha-1 Foundation Letter of Intent Application Instructions 2015-2016 In-Cycle Grants VERSION 1 June 30, 2015 Alpha-1 Foundation 3300 Ponce de Leon Blvd. Coral Gables, FL 33134 TABLE OF CONTENTS I. Introduction
More information